Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19Jeffrey Laurence, Cynthia M. Magro, Madhav Seshadri et al.|Clinical Immunology|2020Cited by 128
TRANSCRIPTIONAL, EPIGENETIC, AND SIGNAL EVENTS IN ANTIFOLATE THERAPEUTICSAlexandra C. Racanelli|VCU Scholars Compass (Virginia Commonwealth University)|2009Cited by 0